Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?

The role of serial NT-proBNP measurements in patients suffering from chronic systolic heart failure (CHF) who already receive individually optimized pharmacotherapy is still unresolved.

Saved in:

Bibliographic Details
Main Authors:	Franke, Jennifer (Author) , Frankenstein, Lutz (Author) , Schellberg, Dieter (Author) , Bajrovic, Amer (Author) , Wolter, Jan Sebastian (Author) , Ehlermann, Philipp (Author) , Dösch, Andreas (Author) , Nelles, Manfred (Author) , Katus, Hugo (Author) , Zugck, Christian (Author)
Format:	Article (Journal)
Language:	English
Published:	16 July 2011
In:	Clinical research in cardiology Year: 2011, Volume: 100, Issue: 12, Pages: 1059-1067
ISSN:	1861-0692
DOI:	10.1007/s00392-011-0340-1
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00392-011-0340-1
Author Notes:	Jennifer Franke, Lutz Frankenstein, Dieter Schellberg, Amer Bajrovic, Jan Sebastian Wolter, Philipp Ehlermann, Andreas O. Doesch, Manfred Nelles, Hugo A. Katus, Christian Zugck

Description
Summary:	The role of serial NT-proBNP measurements in patients suffering from chronic systolic heart failure (CHF) who already receive individually optimized pharmacotherapy is still unresolved.
Item Description:	Gesehen am 27.02.2023
Physical Description:	Online Resource
ISSN:	1861-0692
DOI:	10.1007/s00392-011-0340-1